Solid Biosciences Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $159.4M | $297.1M | $59.9M | $61.4M | $138.9M | $210.6M | $80.2M | $64.4M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $395.1M | $396.8M | $205.5M | $244.9M | $278.6M | $313.4M | $157.3M | $179.5M |
| Property, Plant & Equipment | $4.0M | $3.9M | $4.2M | $4.4M | $4.3M | $4.5M | $4.7M | $5.1M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $420.6M | $422.9M | $232.5M | $273.9M | $308.3M | $343.9M | $188.7M | $211.8M |
| Liabilities | ||||||||
| Accounts Payable | $4.4M | $5.6M | $3.2M | $8.4M | $4.7M | $6.4M | $4.2M | $3.5M |
| Total Current Liabilities | $28.6M | $30.3M | $33.5M | $36.3M | $29.8M | $28.8M | $30.3M | $22.9M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $46.5M | $48.8M | $52.5M | $56.0M | $50.0M | $49.4M | $51.4M | $44.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.07B | $-1.01B | $-957.8M | $-908.0M | $-862.2M | $-822.7M | $-783.5M | $-740.9M |
| Total Stockholders' Equity | $374.1M | $374.1M | $180.0M | $217.9M | $258.3M | $294.5M | $137.2M | $167.0M |